Literature DB >> 17225841

Review of data of the patients receiving total parenteral nutrition at the intensive care unit of a university hospital.

Nimet Ovayolu1, Seda Torun, Ozlem Ucan, Perihan Ozdemir, Hakan Buyukhatipoglu, Yavuz Pehlivan, Ramazan Geyik.   

Abstract

Parenteral nutrition is commonly administered to patients in intensive care units who cannot be fed gastrointestinally. Several problems might be encountered during parenteral nutrition. We designed this study to evaluate two years' data of the patients who received parenteral nutrition at the intensive care unit of the university hospital. Forty-five patients who were treated at this hospital between January 1, 2004 and December 31, 2005 were included in this study. Patient data were collected via questionnaires designed based on the information in the literature. Blood, urinary, oropharyngeal and catheter entry site cultures were obtained and analyzed on the third and seventh days of the treatment. We found the following results: 31.1% of the patients received parenteral nutrition due to renal insufficiency; ready-made amino acid/lipid solutions were used in 86.7% of the patients; 77.8% of the solutions were administered through a peripheral vein; 88.6% of total parenteral nutrition solutions given thorough the peripheral vein had higher osmolarities than 800 mOsmol/L; routine Fe and Fe binding capacity, prothrombin time, cholesterol and triglyceride level assessments were not performed before the initiation of treatment; and the culture tests most commonly revealed Staphylococcus epidermidis in the blood, Candido species in urine, Streptococcus in throat, and Staphylococcus aureus at catheter entry sites. Based on these results, we suggest that organizing a nutrition support team would be useful in order to improve the quality of the nursery and to provide close and rational management and follow-up of the patients receiving total parenteral nutrition.

Entities:  

Mesh:

Year:  2006        PMID: 17225841      PMCID: PMC2569689     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  17 in total

Review 1.  Malnutrition in hospitals. Who's assessing what patients eat?

Authors:  S G Dudek
Journal:  Am J Nurs       Date:  2000-04       Impact factor: 2.220

2.  Education and training in nutrition support pharmacy practice.

Authors:  Roland N Dickerson; Rex O Brown
Journal:  Nutrition       Date:  2003 Jul-Aug       Impact factor: 4.008

Review 3.  Prescribing total parenteral nutrition.

Authors:  Wega Koss; Neel Joshi
Journal:  Nutrition       Date:  2003-09       Impact factor: 4.008

4.  Total parenteral nutrition, intestinal adaptation, and short bowel syndrome.

Authors:  Herbert R Freund; Nahum Beglaibter
Journal:  Nutrition       Date:  2004-03       Impact factor: 4.008

5.  High insulin requirement versus high chromium requirement in patients nourished with total parenteral nutrition.

Authors:  Onnipa Wongseelashote; Margaret A Daly; Eric H Frankel
Journal:  Nutrition       Date:  2004-03       Impact factor: 4.008

6.  Validity of nutritional screening and assessment tools.

Authors:  J Mary Jones
Journal:  Nutrition       Date:  2004-03       Impact factor: 4.008

7.  Early enteral nutrition vs. early parenteral nutrition: an irrelevant question for the critically ill?

Authors:  Daren K Heyland; Rupinder Dhaliwal
Journal:  Crit Care Med       Date:  2005-01       Impact factor: 7.598

8.  Catheter-related infection in patients on home parenteral nutrition: results of a prospective survey.

Authors:  J-M Reimund; Y Arondel; G Finck; F Zimmermann; B Duclos; R Baumann
Journal:  Clin Nutr       Date:  2002-02       Impact factor: 7.324

Review 9.  Perioperative nutrition support: who and how.

Authors:  Richard M Salvino; Robert S Dechicco; Douglas L Seidner
Journal:  Cleve Clin J Med       Date:  2004-04       Impact factor: 2.321

Review 10.  Chromatin effects in nutrition, cancer, and obesity.

Authors:  Mark D Garfinkel; Douglas M Ruden
Journal:  Nutrition       Date:  2004-01       Impact factor: 4.893

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.